Date
17 November 2026
Anticipating future health risks: Abu Dhabi offers a blueprint for African healthcare
The article highlights the persistent barriers that prevent patients living in Africa from obtaining essential medicines, including supply constraints, high prices and limited public financing, particularly in lower-income countries.
Access to Medicine Foundation CEO Jayasree Iyer is quoted emphasising that expanding access to essential medicines requires stronger universal health coverage and public financing. She highlights how the lowest-income African countries often face unfavourable terms or are excluded from agreements with international pharmaceutical companies, and discusses the potential of local and regional manufacturing to strengthen supply security.
She also calls for governments to support local producers through procurement, and for multinational pharmaceutical companies to contribute through licensing, technology transfer and research partnerships. She further highlights voluntary licensing and regulatory harmonisation through the African Medicines Agency as important ways to improve medicine availability and make smaller markets more attractive to manufacturers.